Skip to main content

Table 5 Urine Clinical Safety Markers

From: Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males

 

300 mg

600 mg

Week

0

1

3

8

11

0

1

3

8

11

Glucose

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Ketones

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Blood

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Protein

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Nitrite

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Bilirubin

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Leukocytes

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Specific Gravity

1.02 ± 0.01

1.02 ± 0.01

1.01 ± 0.01

1.02 ± 0.01

1.02 ± 0.01

1.02 ± 0.01

1.02 ± 0.01

1.02 ± 0.01

1.02 ± 0.01

1.02 ± 0.01

pH

5.5 ± 0.76

5.6 ± 0.58

5.9 ± 0.90

5.4 ± 0.68

5.3 ± 0.53

5.8 ± 1.13

5.8 ± 1.13

5.8 ± 1.13

5.8 ± 1.13

5.8 ± 1.13

Urobilinogen (E.U./dl)

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

0.2 ± 0.0

  1. No significant differences were observed (p > 0.05). A zero reading indicates that there were no traceable amounts of markers present. Readings that were above a zero reading indicated a trace amount and are otherwise indicated by numbers 1, 2, and 3.